We know your time is precious so we've drilled down the three most important medtech stories from the past week. But feel free to click the headline to read beyond the blurb.Image by OpenClipart-Vectors on Pixabay
The robotic surgery market is becoming increasingly noisy as new entrants move in and companies like Medtronic and Johnson and Johnson become more vocal about their plans in robotics. This means elongated price negoation timelines and delayed deals for Intuitive Surgical, but the market pioneer seems prepared to handle the extra noise.
Back in 2013, analysts balked at the price Stryker paid to acquire Mako (a whopping $1.6 billion), but the company just reported its strongest robot quarter since launching the ever-popular robot. Globally, Stryker sold 89 Mako robots in Q4 (63 of which were U.S. sales) versus 54 in the comparable quarter a year ago.
It seems The entire world is concerned about the coronavirus, and for good reason. But have no fear U.S. readers, FDA is on the case. The agency has a strategy that will see it working with industry and international partners to diagnose, treat, mitigate, and prevent outbreaks.